The pharmaceutical world is observing a major shift in blood sugar treatment with the arrival of GLP-1 transdermal devices. These patches offer a potentially more comfortable alternative to injections of GLP-1 drugs, reducing the need for daily needle pokes. The innovation releases the compound d